Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective study

doi:10.5312/wjo.v15.i12.1155

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (155)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-5)

Sum=136

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=7

Dec 18, 2024 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Orthop. Dec 18, 2024; 15(12): 1155-1163
Published online Dec 18, 2024. doi: 10.5312/wjo.v15.i12.1155

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall survival of 45 patients with non-small cell lung cancer after bone metastasis diagnosis.

Open in New Tab Full Size Figure Download Figure

Figure 2 The Kaplan–Meier curves for overall survival of patients. A: The Kaplan–Meier curves for overall survival of patients classified according to immune checkpoint inhibitor use; B: The Kaplan–Meier curves for overall survival of patients classified according to tumor proportion score and immune checkpoint inhibitor use. TPS: Tumor proportion score; ICI: Immune checkpoint inhibitor.

Citation: Ishibashi Y, Kobayashi H, Ando T, Okajima K, Oki T, Tsuda Y, Shinoda Y, Sawada R, Tanaka S. Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective study. World J Orthop 2024; 15(12): 1155-1163
URL: https://www.wjgnet.com/2218-5836/full/v15/i12/1155.htm
DOI: https://dx.doi.org/10.5312/wjo.v15.i12.1155